Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe banner announcing NIH’s terminology transition and related updates was removed. The page still displays a 403 Forbidden message instead of the study record.SummaryDifference1%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The study record page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA sitewide banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe site footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details, indicating access to the record is blocked. The surrounding site chrome remains visible, but the main content is not accessible.SummaryDifference19%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.